98%
921
2 minutes
20
Objective: To seek a deeper and more comprehensive understanding of two major diagnostic methods for laryngopharyngeal reflux by exploring whether and how differences exist before and after treatment between patients diagnosed by either Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) or 24-hour pH monitoring.
Materials And Methods: Two groups of patients who confirmed laryngopharyngeal reflux disease (LPRD) by either a combination of RSI and RFS (Questionnaire group, 35 patients) or 24-hour multichannel intraluminal impedance (MII) pH monitoring (pH Group, 23 patients) were recruited. All patients were prescribed esomeprazole 20 mg twice a day for 1 month. RSI, RFS, and acoustic parameters before and after treatment were compared between the two groups. Intrinsic correlations involving multiple parameters were investigated as well.
Results: Except for excess throat mucus (P = 0.019) and subglottic edema (P = 0.042), most RSI and RFS items before treatment were not significantly different between the Questionnaire and pH Groups, and nearly all such items in both groups exhibited distinct remission after therapy (P < 0.05). Absolute value of remission in RSI after treatment was more prominent in pH Group than in the Questionnaire group (P = 0.007). Jitter (P = 0.252), shimmer (P = 0.815), and harmonics-to-noise ratio (P = 0.117) descended to normal value after treatment. Moderate to high levels of correlation were found between the patient's original status and the absolute value of remission in most items of RSI and RFS as well as voice parameters.
Conclusion: The 24-hour MII pH monitoring and a combination of RSI and RFS are quite competitive with each other in selecting LPRD patients. Although treatment worked out on nearly all the symptoms, laryngeal images and voice parameters, 24-hour MII pH seems to be more promising in a greater symptom relief. The extent of relief that can take place in most of the measurements is considerably determined by their initial status.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvoice.2013.12.004 | DOI Listing |
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
August 2025
Department of Otolaryngology, Peking University Third Hospital, Beijing 100191,China.
To explore the clinical and salivary metabolic component characteristics of patients with OSA combined with LPRD, and to investigate the potential co-morbid mechanisms of LPRD and OSA. A total of 98 adult patients with OSA (81 males and 17 females) who visited the Department of Otolaryngology of Peking University Third Hospital from March 2024 to May 2024 were consecutively included. The age ranged from 19 to 68 years (mean±standard deviation: 39.
View Article and Find Full Text PDFZhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
August 2025
Department of Otorhinolaryngology Head and Neck Surgery, the Sixth Medical Center of PLA General Hospital, and National Clinical Research Center for Otolaryngologic Diseases, Beijing 100048, China.
To study the characteristics of laryngopharyngeal reflux (LPR) events in patients with obstructive sleep apnea (OSA). This cross-sectional study analyzed OSA patients who were admitted in the Department of Otolaryngology-Head and Neck Surgery, the Sixth Medical Center of the Chinese PLA General Hospital between November 2020 to July 2023[OSA group, 52 males, 6 females, aged 23-69 (41.22±11.
View Article and Find Full Text PDFSaudi Med J
August 2025
From the Department Surgery (Fageeh, Alhusayni, Aljemyie, Alqurashi, Alolayani, Alaseeri), College of Medicine, Taif University, from the Department of Otorhinolaryngoloy (Alnofaie), King Faisal Medical complex, Taif, and from the Department of Otolaryngology and Head and Neck Surgery (Al-Rasheedi),
Objectives: To assess the prevalence and clinical presentation of laryngopharyngeal reflux (LPR) among adults with chronic tonsillitis and examine how effective reflux treatments are for these patients.
Methods: A prospective observational study was conducted at a tertiary referral hospital from March 2024 to January 2025 on adult participants diagnosed with chronic tonsillitis who presented with tonsillar inflammation and sore throat. The participants were evaluated before and after treatment with proton pump inhibitors (PPIs) and dietary and lifestyle modifications for 3 months.
Indian J Otolaryngol Head Neck Surg
August 2025
Department of Otorhinolarngology and Head & Neck Surgery, Era's Lucknow Medical College and Hospital, Lucknow, India.
Introduction: Laryngopharyngeal reflux (LPR) is a common disease in the outpatient department of otolaryngology and is characterised by backflow of stomach contents into the pharynx and larynx resulting in significant negative impact on the quality of life of patients. The aim of study was to assess the effect of proton pump inhibitor (PPI) on quality of life in patients with LPR.
Method: 110 patients diagnosed with LPR were enrolled in study and prescribed omeprazole (20 mg) twice daily for 12 weeks.
J Clin Med
June 2025
Laryngopharyngeal Reflux Study Group, Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), 13005 Paris, France.
: Chronic rhinosinusitis with or without nasal polyps (CRSwNPs/CRSsNPs) is an inflammatory disease that is becoming increasingly associated with laryngopharyngeal reflux disease (LPRD). Although symptom-based questionnaires, such as the Reflux Symptom Index (RSI) and Reflux Symptom Score (RSS), are widely used, there is a lack of objective endoscopic tools for assessing the nasopharyngeal and nasal manifestations of reflux. The Nasopharyngeal Reflux Endoscopic Score (NRES) is a novel endoscopic scoring system that was developed to address this issue.
View Article and Find Full Text PDF